Monoclonal mouse anti-phospho-ERK1/2 and rabbit monoclonal anti-5-HT antibodies were from Sigma-Aldrich (Stockholm, Sweden). Mouse anti-NeuN monoclonal antibody was purchased from Millipore (Stockholm, Sweden). Secondary infrared probe-labelled rabbit-anti-mouse antibodies were from LI-COR Biosciences (Stockholm, Sweden). Alexa
Fluor 488-conjugated goat anti-mouse IgG and the Alexa Fluor 546-conjugated goat antirabbit IgG were from Invitrogene (Stockholm, Sweden).
Plasmid constructs.
The cDNA encoding the human 5-HT1A and FGFR1 without its stop codon was subcloned in pGFP 2 -N1 (Perkin-Elmer, Madrid, Spain) and pEYFP-N1
(Clontech, Heidelberg, Germany) using standard molecular biology and PCR techniques. has been demonstrated previously [12, 16] . Immediately before use, the peptides were solubilised in dimethyl sulfoxide (DMSO) and diluted in the corresponding cell culture medium to yield a final concentration of 1% DMSO. We verified that, for each tested concentration of DMSO alone, no effect on cell viability was observed. Cells were incubated with the above mentioned peptides at 37°C for two hours prior to performing FRET analysis or signalling assays. Incorporation of the peptide into cellular membranes under these conditions was checked with a rhodamine-labeled TM-I peptide. 
